# Omacor Plus Standard Therapies In Post Myocardial Infarction (MI) Subjects Evaluation: The OPTIMISE Observational Study

> **NCT01632878** · — · COMPLETED · sponsor: **Mylan Inc.** · enrollment: 1531 (actual)

## Conditions studied

- Myocardial Infarction (MI)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01632878
- **Lead sponsor:** Mylan Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 1531 (ACTUAL)
- **Last updated:** 2022-03-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01632878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01632878, "Omacor Plus Standard Therapies In Post Myocardial Infarction (MI) Subjects Evaluation: The OPTIMISE Observational Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01632878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*